Brief: Setpoint Medical - Funds Will Be Used To Complete Ongoing Reset-Ra Study, FDA Regulatory Submissions
19/01/2023 13:14
Jan 19 (Reuters) - Runway Growth Finance Corp RWAY.O :
* SETPOINT MEDICAL - FUNDS WILL BE USED TO COMPLETE ONGOING
RESET-RA STUDY, FDA REGULATORY SUBMISSIONS
* SETPOINT MEDICAL ANNOUNCES EXPANDED $65M CREDIT FACILITY
TO
SUPPORT DEVELOPMENT OF THE COMPANY’S NOVEL PLATFORM FOR
RHEUMATOID ARTHRITIS
* SETPOINT MEDICAL - FUNDS WILL BE USED FOR EARLY
COMMERCIALIZATION FOR COMPANY'S RHEUMATOID ARTHRITIS INDICATION
Further company coverage: RWAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Runway Growth Finance
See all newsBrief: Runway Growth Finance Corp. Prices Offering Of 7.75% Notes Due 2031
Brief: Runway Growth Finance Corp Commences Offering Of Notes
U.S. STOCKS ON THE MOVE-SpaceX, Federal Realty, Celsius Holdings
U.S. STOCKS ON THE MOVE-Atlassian, Macerich, DoubleVerify
Runway Growth Finance climbs after higher Q2 net investment income